Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario

View ORCID ProfileSonia S Anand, Corey Arnold, Shrikant Bangdiwala, Shelly Bolotin, Dawn Bowdish, Rahul Chanchlani, View ORCID ProfileRussell de Souza, Dipika Desai, Sujane Kandasamy, Farah Khan, Zainab Khan, Marc-André Langlois, Jayneel Limbachia, Scott Lear, Mark Loeb, Lawrence Loh, Baanu Manoharan, Kiran Nakka, Martin Pelchat, View ORCID ProfileZubin Punthakee, Karleen Schulze, Natalie Williams, Gita Wahi
doi: https://doi.org/10.1101/2022.04.01.22273252
Sonia S Anand
1McMaster University, Department of Medicine
2Population Health Research Institute
MD PhD FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sonia S Anand
  • For correspondence: anands{at}mcmaster.ca
Corey Arnold
3University of Ottawa, Department of Biochemistry, Microbiology, and Immunology
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shrikant Bangdiwala
2Population Health Research Institute
4McMaster University, Department of Health Research Methods, Evidence, and Impact
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelly Bolotin
5Public Health Ontario
6University of Toronto, Dalla Lana School of Public Health
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawn Bowdish
1McMaster University, Department of Medicine
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahul Chanchlani
7McMaster University, Department of Pediatrics
MD MSc MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell de Souza
2Population Health Research Institute
4McMaster University, Department of Health Research Methods, Evidence, and Impact
ScD RD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Russell de Souza
Dipika Desai
2Population Health Research Institute
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sujane Kandasamy
4McMaster University, Department of Health Research Methods, Evidence, and Impact
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farah Khan
2Population Health Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zainab Khan
2Population Health Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc-André Langlois
3University of Ottawa, Department of Biochemistry, Microbiology, and Immunology
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jayneel Limbachia
2Population Health Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Lear
8Faculty of Health Sciences, Simon Fraser University
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Loeb
4McMaster University, Department of Health Research Methods, Evidence, and Impact
9Department of Pathology and Molecular Medicine
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Loh
6University of Toronto, Dalla Lana School of Public Health
MD MPH FCFP FRCPC FACPM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baanu Manoharan
4McMaster University, Department of Health Research Methods, Evidence, and Impact
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiran Nakka
3University of Ottawa, Department of Biochemistry, Microbiology, and Immunology
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Pelchat
3University of Ottawa, Department of Biochemistry, Microbiology, and Immunology
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zubin Punthakee
1McMaster University, Department of Medicine
2Population Health Research Institute
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zubin Punthakee
Karleen Schulze
2Population Health Research Institute
MMath
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Williams
1McMaster University, Department of Medicine
MLIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gita Wahi
7McMaster University, Department of Pediatrics
MD FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background South Asians represent the largest non-white ethnic group in Canada. The Greater Toronto Area (GTA), home to a high proportion of South Asians, emerged as a COVID-19 hot spot. Early in the pandemic, the South Asian community was identified as having risk factors for exposure and specific barriers to accessing testing and reliable health information, rendering them uniquely vulnerable to SARS-CoV-2 infection.

Objectives To investigate the burden of SARS-CoV-2 infection among South Asians in the GTA, and to determine which demographic characteristics were most closely aligned with seropositivity, in this cross-sectional analysis of a prospective cohort study.

Methods Participants from the GTA were enrolled between April and July 2021. Seropositivity for anti-spike and anti-nucleocapsid antibodies was determined from dried blood spots, and age and sex standardized to the Ontario South Asian population. Demographics, risk perceptions, and sources of COVID-19 information were collected via questionnaire in a subset.

Results Among the 916 South Asians enrolled, mean age 41 years, the age and sex standardized seropositivity was 23.6% (95% CI: 20.8%-26.4%). Approximately one-third identified as essential workers, and 19% reported living in a multi-generational household. Over half perceived high COVID-19 risk due to their geographic location, and 36% due to their type of employment. The top three most trusted sources of COVID-related information included healthcare providers/public health, traditional media sources, and social media.

Conclusion By the third wave of the COVID-19 pandemic, approximately one-quarter of a sample of South Asians in Ontario had serologic evidence of prior SARS-CoV-2 infection. Insight into factors that render certain populations at risk can help future pandemic planning and disease control efforts.

Background

The novel SARS-CoV-2 virus was declared a global pandemic in March 2020. Within Canada, COVID-19 hotspots emerged, and attention was drawn to these regions by the high infection and hospitalization rates and need to transfer patients outside of these regions to receive intensive care. South Asians (i.e., people who originate from the Indian subcontinent) are the largest non-white ethnic group in Canada (1) and have been disproportionally affected by COVID-19 (2). More than half of the residents of the Region of Peel, in the Greater Toronto Area (GTA), Ontario identify as South Asian (3).

Peel is divided into three cites - Caledon, Brampton, and Mississauga. Brampton has a population of 600,000; and over one-third of residents are South Asian, rising in some areas to nearly two thirds (4). In the first wave of the COVID-10 pandemic in Ontario [March to September 2020], the SARS-CoV-2 infection rate was almost twice as high in the City of Brampton, compared to the rate in neighbouring Mississauga (711 vs 390 cases per 100,000 people) (2). Peel emerged as a hotspot in Ontario, accounting for 22% of provincial cases during the second wave, beginning in September 2020 (2,5), although making up only 10% of the province’s population (Figure 1), with the City of Brampton as the epicentre. Public Health Ontario provided indirect measures of the impact on the South Asian populations, showing the rates of infection, hospitalization, intensive care unit admission and death rates by quintiles of diversity in Ontario. People in the most diverse neighbourhoods were more likely to be new immigrants, younger, living in larger households, and had three times higher infection, four times the hospitalization, four times the intensive care unit admission, and two times the death rate from COVID-19 as compared to less diverse communities (6). Early in the pandemic, there was limited availability of SARS-CoV-2 laboratory testing throughout Ontario. In hotspot communities, like Peel, this was compounded by other access barriers to health care which pre-dated the pandemic, which resulted in a high burden of infection (2). However, action by local and provincial public health officials, combined with advocacy from community groups and the media (7) resulted in increased resources for testing and prioritization of vaccine roll-out, which commenced in April 2021 (8).

Figure 1:
  • Download figure
  • Open in new tab
Figure 1: Data from Public Health Ontario: COVID-19 Pandemic Comparing Peel Region to Ontario (30).

Here we report the seroprevalence of SARS-CoV-2 infection in this ethnic group who were recruited during Wave 3 of the pandemic, [March 2021 to June 2021] and report the factors which correlate with infection.

Design and Methods

The COVID CommUNITY study is a prospective cohort study focused on South Asian adults living in Canada, in the provinces of Ontario and British Columbia. In this cross-sectional analysis, we present data from the baseline assessment of the Ontario sub-cohort recruited between April 14, to July 28, 2021. All participants provided informed consent and this study was approved by Hamilton Integrated Research Ethics Board (13323 - March 24, 2021).

This study was funded by the COVID-19 Immune Task Force (CITF), and funds distributed from the Public Health Agency of Canada.

Study Population

Adults ≥ 18 years of age and South Asian were eligible. South Asian ethnicity was self-reported and defined by parental South Asian ancestry from the Indian subcontinent, Africa, Caribbean, and Guyana.

Recruitment

Recruitment was predominantly from vaccination centres in Brampton immediately after receiving dose 1 (Pre-vaccination group), or > 24 hours after receiving dose one or two of vaccination (Post vaccination group). A smaller proportion came from places of worship, SARS-CoV-2 testing centre in Brampton, through social media, and by inviting participants of South Asian origin from an existing cohort study (9). At the time of consent, dried blood spots (DBS) were collected along with key sociodemographic information, and vaccination status. Additional information regarding employment type, health history, prior SARS-CoV-2 infection, perception of SARS-CoV-2 infection risk, primary and trusted sources of COVID-19 information was collected on a web-based survey.

Laboratory measurements

DBS were collected in person at recruitment sites, and through the mail for social media and cohort recruitment. For home collection, an instructional video and self-addressed stamped envelope was provided for mail returns. Blood was collected on the WhatmanTM 903® Protein Saver Cards. Batched specimens were sent for analysis to the CITF-funded lab of our collaborator (Dr. Langlois) for analysis and were processed and analyzed using a high throughput ELISA assay (10,11). The main assays focused on the parallel detection of immunoglobulin IgG against the spike trimer (S), and the nucleocapsid (N) protein with standardized antigens to S, and N produced by the National Research Council of Canada laboratory. This method has been used in prior studies (12), and detailed methods are described elsewhere (12,13). The IgG-based ELISAs measure antibody levels in single-point measurements in reference to a standard antibody curve to accurately distinguish individuals with previous infection or vaccination from those who have not been infected or vaccinated (Area Under the Receiver Operating Curve > 0.96 for each assay).

Evidence of previous infection was defined in pre-vaccinated participants (i.e. – those unvaccinated or those submitting samples immediately after receiving vaccine) as individuals with test results having signal to cutoff ratios ≥1 for both anti-S and anti-N IgG, or anti-S≥ 1 and a history of SARS-CoV-2 infection. Evidence of previous infection among vaccinated individuals (i.e. those who submitted a DBS sample >1 day after vaccination) was defined as an anti-N IgG results of ≥ 1. A range of strict definition and lenient definition in the pre-vaccination group was also examined and defined as a) IgG S and IgG N ≥ 1, and b) IgG S ≥ 1, respectively. The false discovery rate (FDR) was set at 2% for the IgG S, and 3% for IgG to N; These cut-offs have > 98% accuracy when validated by the National Microbiology Laboratory reference panel (11). The background seasonal coronavirus antibody mean titers in the Ottawa region was used as reference (10,13).

Statistical Analysis

The proportion of participants who had evidence of prior SARS-CoV-2 infection is compared to the infection rate in similar forward sortation areas (FSA). Risk factors for SARS-CoV-2 infection, sources of health information, and perception of SARS-CoV-2 risk are reported as percentages or means (SD) for the overall cohort, and for comparing seropositive to non-infected participants. Non-responders to the follow-up survey were compared to responders for age, sex, income, location, and seroprevalence. As this sample was not a random sample of the population, the risk of bias was assessed with a modified Joanna Briggs instrument (JBI) Critical Appraisal Checklist for Prevalence Studies (14). This tool evaluates the external and internal validity of the study using the CocoPop mnemonic (Condition, Context, Population) (15). The overall risk of bias was determined based on the criteria met and the impact any criteria that were not met have on the validity and reliability of the prevalence estimate (14). Items include questions on the sampling frame, sampling method, sample size, coverage, validity, and reliability of the condition measured, statistical analysis, and response rate, as shown in Supplementary Table 1.

Results

Recruitment into the COVID CommUNITY study in Ontario began on April 14, 2021, and 939 participants recruited, and a DBS collected up to July 28, 2021. Of 939 participants, 916 participants DBS were analyzed, and 75.7% of these participants completed the follow-up web-survey (Supplementary Figure 1). Participants who did not complete the survey were older, and more likely to be seropositive, although no significant differences in location of recruitment, household income, or sex were observed (Supplementary Table 2).

Demographic Characteristics

Characteristics of the overall cohort are shown in Table 1. The average age of participants was 41.5 years (14.4), and 49% were women. Briefly, over 90% of participants lived in the Peel Region, the majority (82%) from the City of Brampton. About two-thirds of participants were born in Canada or had lived in Canada more than 10 years. Most participants (78%) had completed post-secondary education, and 72% were employed. Almost 33% of participants’ jobs were classified as essential work using the Ontario Government classification (i.e., food manufacturing and transportation workers), and an additional 16% of participants preferred not to answer this question. Although multigenerational household data were incomplete, of the 576 participants who completed this section, 19% reported living in a multigenerational household, with an additional 12% who preferred not to answer. The most common mother tongue reported included Punjabi or Urdu, followed by Gujarati, and Hindi. Demographic characteristics by pre- or post vaccination status are found in Supplementary Table 3.

View this table:
  • View inline
  • View popup
Table 1: Demographic Characteristics

Seropositivity

The proportion of seropositive cases by geographic region (FSA) are shown in comparison to the cumulative incidence of SARS-CoV-2 infection rate (Figure 2). The age-sex standardized seropositivity for previous infection was 23.6% (95% CI: 20.8 to 26.4). Among the 458 participants without a prior vaccination, the seroprevalence was 26.9% (95% CI: 22.8 to 31.0) compared to 21.3% (95% CI: 17.5 to 25.1) in the 458 participants who had received at least one dose of the COVID-19 vaccine (393 received one, 65 had received 2 doses). The seropositivity ranged from 22.7% applying the strict definition of seropositivity, to 27.4% using the lenient definition. The risk of bias assessment was classified as moderate, attributed to the complex, multiprong, non-probability sampling method of recruitment (Supplementary Table 1). The seropositivity was higher in men, older ages, lower education, living in multigenerational households, and from the City of Brampton. Of participants who were seropositive, 53% did not report previous SARS-CoV-2 infection (Table 2).

View this table:
  • View inline
  • View popup
Table 2: Seropositivity by Demographics
Figure 2:
  • Download figure
  • Open in new tab
Figure 2: Cumulative Incidence of COVID-19 cases (per 100) as of Oct 3, 2021 by Age-Sex Standardized Seroprevalence by FSA. Cumulative Incidence data from Institute of Clinical Evaluative Sciences (31).

Risk Perception

Of those who completed the risk perception questionnaire (Table 3), 92% reported COVID-19 posed a major threat to the South Asian community, 51% agreed or strongly agreed that they were at high risk from COVID-19 because of their location, 35% reported being high risk because of their work or profession, 14% because of socializing or lifestyle, and 14% because of their housing situation.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3: Risk Perception

Sources of Health Information

The top ranked health information sources included healthcare providers or provincial public health bodies (52%), traditional media sources (TV news channels, newspapers) (45%), social media (28%), and friends, family or coworkers (26%) (Figure 3).

Figure 3:
  • Download figure
  • Open in new tab
Figure 3: Top 3 most Trusted Sources of COVID Health Information Sources according to respondents (N=585 respondents).

Discussion

Among a sample of South Asians recruited primarily from a designated hot spot in the GTA, we report a seroprevalence of SARS-CoV-2 of 23.6% (95% CI: 20.8 to 26.4), which is standardized by age and sex to the Ontario South Asian population. The range in seropositivity using the strict definition to lenient definition was 22% to 27%. The risk of bias assessment was classified as moderate, attributed to the non-probability sampling method. This report confirms other sources of evidence that racialized groups in general, as well as South Asians, specifically in the GTA, represent a high-risk group for SARS-CoV-2 infection (7). Since it utilizes serological testing, it captures infection rate more comprehensively than routine data sources, which rely on SARS-CoV-2 infection PCR testing.

Prior to the COVID-19 pandemic, ethnicity data are not routinely collected or made publicly available in Canada (16). As a surrogate, in areas where a single ethnic group is concentrated, infection and hospitalization rates can be examined by postal code, and then inferred to be representative of high-density ethnic populations (6). However, our data provide direct evidence of the high infection rate suffered by South Asians in the Peel Region. The reasons for this are multiple, and include socio-cultural factors including socioeconomic inequity, multigenerational households, barriers to accessing healthcare including SARS-CoV-2 testing, and the higher percentage of workers who were essential workers in factories, manufacturing, Amazon Inc. centres, and the trucking industry (17-19). Immigrants are overrepresented in meat, food and beverage processing plants, trucking, and in health and long-term care as nurses’ aides and orderlies. The reasons for overrepresentation include the low pay and lack of benefits and protections, features not desired by others who can pursue jobs in other sectors (20,21). Almost 33% of participants in our study reported doing essential work, although an additional 12% preferred not to answer this question, and 19% reported living in a multigenerational household, with an additional 12% preferring not to answer. Participants who indicated they “preferred not to answer” may reflect the stigmatization they may have felt during the initial waves of the pandemic. Therefore, the proportion of essential workers and those living in multigenerational households may be underestimates, especially considering our observation that participants who did not complete the follow-up survey where this information was collected, were more likely to be seropositive for SARS-CoV-2 (Supplementary Table 2).

Our seropositivity data mirrors the high infection rate when comparing FSAs in the City of Brampton and Peel Region (Figure 2). The seropositivity rate was higher in men compared to women, those with lower educational attainment, those living in Brampton, and in multigenerational households. Higher seropositivity of 2 to 3-fold has been reported in ethnic minority groups including Black and South Asian people compared to white people living in the United Kingdom (22,23). Compared to population-based seroprevalence studies conducted during the third wave of the pandemic in Canada such as the Canadian Blood Services with a seropositivity for previous infection of 3.95%, we observed a relatively high rate of seropositivity among South Asians in the GTA (23.6%) (24). However, a similarly high rate of seropositivity (22%) was reported among a cross-sectional study of 1,100 incarcerated men in Canada attributed to enhanced daily interactions in a congregate setting (25).

During the initial waves of the pandemic, it was unclear if standard public health messaging by public health officials at the Federal, Provincial, and local levels was reaching communities at high-risk such as South Asians (26). Our data, collected during the third pandemic wave, show that the top sources of information utilized by our cohort included information from healthcare providers or Public Health, traditional media sources, and social media (Figure 3). It is possible that our findings reflect the impact of activities of South Asian advocacy groups to raise awareness of health risks, and testing for SARS-CoV-2 infection, including provision of health information in multiple South Asian languages. For example, at the outset of the second wave of the pandemic, a physician-led group, named the South Asian COVID task force, opened a culturally sensitive testing centre in the Embassy Grand convention centre, with Punjabi signage and information translated into multiple South Asian languages, which was funded for and supported by Peel Public Health (27,28). Another advocacy group, the South Asian Health Network advocated for isolation centres; sick pay and time off work for testing and vaccination for essential workers, and COVID-19 information sessions regularly (29). Finally, Peel Public Health worked closely with community leaders to provide outreach onsite for essential workers, initiate testing at workplaces, and to develop mass vaccine centres with cultural sensitivity (16).

Finally, over 90% of the South Asian participants reported COVID-19 posed a major threat to the South Asian community, almost half reported their risk of acquiring COVID-19 was high due to their location, and more than 40% reported their risk was high due to their type of employment. In comparison, the minority of participants perceived their risk of COVID to be due to their lifestyle, such as socializing, or to their housing situation.

Limitations of our analysis include recruitment from vaccination centres, which may attract more health-conscious individuals, the selection of whom could lead to an underestimate of the true seroprevalence (Supplementary Table 1). Further, the history of COVID-19 infection was based on self-reporting which is less reliable than laboratory confirmed diagnosis.

Conclusion

The COVID-19 pandemic was particularly devasting for the South Asian community in the GTA, Ontario. In this analysis, we show the seropositivity data confirms a high infection rate of 23.6% from samples collected during the peak of Wave 3. Planning for future COVID-19 waves should incorporate an understanding of socio-cultural determinants of such high-risk communities.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Study Team

Principal Investigator: Dr Sonia S Anand

Co-investigators: Dr. Shrikant Bangdiwala; Dr. Shelly Bolotin; Dr. Dawn Bowdish; Dr. Rahul Chanchlani; Dr. Russell de Souza; Dr. Sujane Kadasamy, Dr. Marc Andre Langlois, Dr. Scott Lear; Dr. Mark Loeb; Dr. Lawrence Loh, Dr. Zubin Punthakee; Dr. Gita Wahi

Project Office: Program Manager - Dipika Desai; Senior Research Coordinator - Dr. Jodi Miller; Junior Research Coordinator - Andrea Rogge, Sherry Zafar; Statistician - Karleen Schulze; Database Management: Marsella Bishop, Natalie Williams

Ontario Recruitment Team: Site Coordinator: Farah Khan; Research Assistants - Zainab Khan, Jayneel Limbachia

Student Volunteers: Rabeeyah Ahmed, Archchun Ariyarajah, Riddhi Chabrota, Yajur Iyengar, Lokeesan Kaneshwaran, Elias Larrazabal, Hemantika Mahesh, Baanu Manoharan, Rhea Murti, David Nash, Nisarg Radadia, Khyathi Rao, Anand Sergeant, Rhea Varghese

Dr. Marc-Andre Langlois Serology Lab: Corey Arnold, Martin Pelchat, Kiran Nakka.

Acknowledgements

We acknowledge the funder of this work COVID-19 Immunity Task Force (CITF), Public Health Agency of Canada. We acknowledge the advocacy support of the South Asian COVID-19 Task Force, and the South Asian Health Network, and Peel Public Health. Dr. Anand holds a Canada Research Chair (Tier 1) Ethnic Diversity and Cardiovascular Disease, and Michael G. DeGroote Heart and Stroke Foundation Chair in Population Health; Dr. Marc-Andre Langlois holds a Canada Research Chair in Molecular Virology and Intrinsic Immunity. Dr. Dawn Bowdish holds a Canada Research Chair in Aging & Immunity.

Footnotes

  • Declaration of competing interests: M. L. has received vaccine advisory board consulting fees for Seqirus, Pfizer, Merck, Sanofi, Medicago; grant funding for vaccine trial from Seqirus; in-kind vaccine from Sanofi for a trial; and is on the Vaccine Data Safety Monitoring board for Medicago, NIH, CanSino biologics.

References

  1. 1.↵
    Canada [Country] and Canada [Country] (table). Census Profile. 2016 Census. Statistics Canada Catalogue no. 98-316-X2016001. Statistics Canada. 2017. Available from: https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/index.cfm?Lang=E.
  2. 2.↵
    Nasser S. Brampton has emerged as one of Ontario’s COVID-19 hotspots, but experts urge caution on where to lay blame. CBC News [Internet]. 2020 Sep 14. Available from: https://www.cbc.ca/news/canada/toronto/brampton-coronavirus-covid-19-south-asian-1.5723330.
  3. 3.↵
    Region of Peel. 2016 Census Bulletin. Immigration and Ethnic Diversity [Internet]. 2017. Available from: https://www.peelregion.ca/planning-maps/CensusBulletins/2016-immigration-ethnic-diversity.pdf.
  4. 4.↵
    Brampton, CY [Census subdivision], Ontario and Peel, RM [Census division], Ontario(table). Census Profile. 2016 Census. Statistics Canada Catalogue no. 98-316-X2016001. Statistics Canada. 2017. Available from: https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/index.cfm?Lang=E.
  5. 5.↵
    Ontario Agency for Health Protection and Promotion (Public Health Ontario). Weekly epidemiologic summary: COVID-19 in Ontario – focus on September 13, 2020 to September 19, 2020. Toronto, ON: Queen’s Printer for Ontario; 2020. Available from: https://files.ontario.ca/moh-covid-19-weekly-epi-report-en-2020-09-19.pdf.
  6. 6.↵
    Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 in Ontario - A Focus on Diversity: January 15, 2020 to May 14, 2020 Toronto, ON: Queen’s Printer for Ontario; 2020. Available from: https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/06/covid-19-epi-diversity.pdf?la=en.
  7. 7.↵
    McKenzie K. Socio-demographic data collection and equity in covid-19 in Toronto. EClinicalMedicine. 2021;34. doi:10.1016/j.eclinm.2021.100812
    OpenUrlCrossRef
  8. 8.↵
    Wilson C. Ont. prioritizing everyone 18+ in hardest hit neighbourhoods as part of Phase 2 of vaccine rollout. CP24 [Internet]. 2021 Apr 7. Available from: https://www.cp24.com/news/ont-prioritizing-everyone-18-in-hardest-hit-neighbourhoods-as-part-of-phase-2-of-vaccine-rollout-1.5378057.
  9. 9.↵
    Anand SS, Samaan Z, Middleton C, Irvine J, Desai D, Schulze KM, et al. A Digital Health Intervention to Lower Cardiovascular Risk: A Randomized Clinical Trial. JAMA Cardiol. 2016;1(5):601–606. doi:10.1001/jamacardio.2016.1035
    OpenUrlCrossRef
  10. 10.↵
    Colwill KG, Yannick S, Matthew G, Christian A, Corey R, Bhavisha A, et al. A “Made-in-Canada” serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination [preprint]. medRxiv. 2021 Oct. 26. doi: 10.1101/2021.10.25.21265476.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Cholette F, Mesa C, Harris A, Ellis H, Cachero K, Lacap P, et al. Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison [preprint]. Research Square. 2021 Apr. 1. doi: 10.21203/rs.3.rs-366992/v1.
    OpenUrlCrossRef
  12. 12.↵
    Tang X, Sharma A, Pasic M, Brown P, Colwill K, Gelband H, et al. SARS-CoV-2 seroprevalence during the first and second pandemic waves in Canada [preprint]. SSRN. 2021.
  13. 13.↵
    Galipeau Y, Siragam V, Laroche G, Marion E, Greig M, McGuinty M, et al. Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2 [preprint]. medRxiv. 2021 Jan. 1. doi: 10.1101/2021.07.16.21260079.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, et al. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PLoS One. 2021;16(6):e0252617. doi:10.1371/journal.pone.0252617
    OpenUrlCrossRef
  15. 15.↵
    Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147–53.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Rocha R, Carman T. How tracking ethnicity and occupation data is helping fight COVID-19. CBC News [Internet] 2021 Jun 14. Available from: https://www.cbc.ca/news/canada/how-tracking-ethnicity-and-occupation-data-is-helping-fight-covid-19-1.6060900.
  17. 17.↵
    Nagar R. Stop stigmatizing South Asians for high infection rates. CBC News [Internet]. 2020 Dec 8. Available from: https://www.cbc.ca/news/canada/calgary/road-ahead-calgary-south-asian-covid-stigma-1.5831196.
  18. 18.
    Vohra M, Brar A, Banerjee AT. ‘It’s not Diwali, it’s precarious employment and less health care resources.’ South Asian medical experts on Brampton’s rising COVID-19 cases. Toronto Star [Internet]. 2020 Nov 19. Available from: https://www.thestar.com/opinion/contributors/2020/11/19/its-not-diwali-its-precarious-employment-and-less-health-care-resources-south-asian-medical-experts-on-bramptons-rising-covid-19-cases.html?li_source=LI&li_medium=star_web_ymbii.
  19. 19.↵
    Weikle B. COVID-19 hotspot Brampton, Ont., chronically underfunded in community health services, local advocate says. CBC Radio [Internet]. 2020 Dec 4. Available from: https://www.cbc.ca/radio/whitecoat/covid-19-hotspot-brampton-ont-chronically-underfunded-in-community-health-services-local-advocate-says-1.5823815.
  20. 20.↵
    Region of Peel. COVID-19 and the Social Determinants of Health: Race and Occupation [Internet]. 2020. Available from: https://www.peelregion.ca/coronavirus/_media/COVID-19-race-and-occupation.pdf.
  21. 21.↵
    The Conference Board of Canada. Essential Work [Internet]. 2021. Available from: https://www.conferenceboard.ca/temp/88efd5a8-c5f7-46dc-9643-fc2c0cf4ee09/11353_summary_for_execs_essential-work_immigrant-talent.pdf.
  22. 22.↵
    Ward H, Atchison C, Whitaker M, Ainslie KE, Elliott J, Okell L. Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults [preprint]. medRxiv. 2021.
  23. 23.↵
    Chen X, Chen Z, Azman AS, Deng X, Sun R, Zhao Z, et al. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(5):E598-#609.
  24. 24.↵
    O’Brien S. Associate Director of Canadian Blood Services. Personal communication by email. 2021.
  25. 25.↵
    Kronfi N, Dussault C, Maheu-Giroux M, Halavrezos A, Chalifoux S, Sherman J, et al. Seroprevalence and Risk Factors for SARS-CoV-2 Among Incarcerated Adult Men in Quebec, Canada (2021): A Cross-Sectional Study [preprint]. SSRN. 2021.
  26. 26.↵
    Bangdiwala SI, Gomez A, Monsalves MJ, Palmeiro Y. Statistical considerations when communicating health risks: Experiences from Canada, Chile, Ecuador, and England facing COVID-19. Social and Health Sciences. 2021;19(1): 52–79.
    OpenUrl
  27. 27.↵
    Gamrot S. New COVID-19 testing centre to open in Brampton. Brampton Guardian [Internet]. 2021 Jan 21. Available from: https://www.bramptonguardian.com/news-story/10314339-new-covid-19-testing-centre-to-open-in-brampton/.
  28. 28.↵
    Cornwell S. Data shows 83 per cent of COVID-19 cases was among racialized communities in Brampton, Caledon and Mississauga. Brampton Guardian [Internet]. 2021 Mar 3. Available from: https://www.thestar.com/local-brampton/news/2021/03/03/data-shows-83-per-cent-of-covid-19-cases-was-among-racialized-communities-in-brampton-caledon-and-mississauga.html.
  29. 29.↵
    Brar A, Jimenez C. 1 in 4 COVID-19 cases found through contact tracing in Peel were those who went to work sick. Data reveals how Ontario’s lack of paid sick legislation fails vulnerable workers. Toronto Star [Internet]. 2021 Feb 3. Available from: https://www.thestar.com/opinion/contributors/2021/02/03/1-in-4-covid-19-cases-found-through-contact-tracing-in-peel-were-those-went-to-work-sick-data-reveals-how-ontarios-lack-of-paid-sick-legislation-fails-vulnerable-workers.html.
  30. 30.↵
    Ontario COVID-19 Data Tool [Internet]. Public Health Ontario. 2021. Available from: https://www.publichealthontario.ca/en/data-and-analysis/infectious-disease/covid-19-data-surveillance/covid-19-data-tool?tab=trends.
  31. 31.↵
    ICES COVID-19 Dashboard [Internet]. Applied Health Research Questions (AHRQ) 2020. Available from: https://www.ices.on.ca/~/media/Files/COVID-19/ICES-COVID19-Vaccination-Data-by-FSA.ashx?la=en-CA.
Back to top
PreviousNext
Posted April 01, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario
Sonia S Anand, Corey Arnold, Shrikant Bangdiwala, Shelly Bolotin, Dawn Bowdish, Rahul Chanchlani, Russell de Souza, Dipika Desai, Sujane Kandasamy, Farah Khan, Zainab Khan, Marc-André Langlois, Jayneel Limbachia, Scott Lear, Mark Loeb, Lawrence Loh, Baanu Manoharan, Kiran Nakka, Martin Pelchat, Zubin Punthakee, Karleen Schulze, Natalie Williams, Gita Wahi
medRxiv 2022.04.01.22273252; doi: https://doi.org/10.1101/2022.04.01.22273252
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario
Sonia S Anand, Corey Arnold, Shrikant Bangdiwala, Shelly Bolotin, Dawn Bowdish, Rahul Chanchlani, Russell de Souza, Dipika Desai, Sujane Kandasamy, Farah Khan, Zainab Khan, Marc-André Langlois, Jayneel Limbachia, Scott Lear, Mark Loeb, Lawrence Loh, Baanu Manoharan, Kiran Nakka, Martin Pelchat, Zubin Punthakee, Karleen Schulze, Natalie Williams, Gita Wahi
medRxiv 2022.04.01.22273252; doi: https://doi.org/10.1101/2022.04.01.22273252

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)